arrow
W

Wenwen Guo

institute of hematology & blood diseases hospital
H指数:6
被引数:142

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EASIX and sC5b-9 for early identification of adults at high risk of developing TA-TMA after allo-HCT

EASIX和sC5b-9用于异基因造血干细胞移植后高危发生TA-TMA的成人早期识别

2026-07-240
PRE
CBFB::MYH11 MRD after the second chemotherapy cycle: a guide for allogeneic transplantation in favorable-risk AML

CBFB::MYH11 MRD在第二次化疗周期后的检测:在低危急性髓系白血病异基因移植中的指导作用

2026-05-140
PRE
Decitabine in combination with idarubicin within a modified busulfan/cyclophosphamide conditioning regimen for patients with advanced myelodysplastic syndrome: A prospective multicenter clinical cohort study
2024-02-021
OAAI
The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases
2023-01-023
OAAI